Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation

Transplant Proc. 2002 Jun;34(4):1121-3. doi: 10.1016/s0041-1345(02)02794-x.

Authors

D L Sigalet¹, P C Thorne, G R Martin, R E Garola, R W Yatscoff

Affiliation

¹ GI Research Group, University of Calgary and Alberta Children's Hospital, Calgary, Alberta, Canada. sigalet@ucalgary.ca

PMID: 12072293
DOI: 10.1016/s0041-1345(02)02794-x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animal Nutritional Physiological Phenomena
Animals
Cyclosporine / therapeutic use*
Drug Therapy, Combination
Graft Rejection / prevention & control*
Graft Survival / drug effects
Graft Survival / physiology
Immunosuppressive Agents / pharmacology*
Intestinal Absorption / drug effects
Intestinal Absorption / physiology*
Intestine, Small / transplantation*
Male
Models, Animal
Mycophenolic Acid / analogs & derivatives*
Mycophenolic Acid / pharmacology*
Rats
Rats, Inbred Lew
Rats, Sprague-Dawley
Sirolimus / pharmacology*
Transplantation, Homologous / immunology*

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid
Sirolimus